Ikena Oncology
Utility Patent Applications

Last updated:

List of all Ikena Oncology patents 9 in total

Status Patent
Application
Utility: TEAD INHIBITORS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: INDOLE AHR INHIBITORS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 12 May 2022
Application
Utility: ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: POLYMORPHIC COMPOUNDS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 19 Aug 2021
Application
Utility: ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE TREATMENT OF CANCER External link
Filling date: 8 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: AHR INHIBITORS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: TEAD INHIBITORS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: INDOLE AHR INHIBITORS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 22 Oct 2020

Showing 1 to 9 of 9 patents.